Industri

Accessibility through agility: Building manufacturing a...

Across the pharmaceutical industry, one thing is clear: being efficient doesn’t...

Why life sciences leaders need D&O cover that keeps pac...

Leading a life sciences company comes with a unique level of responsibility. Th...

FDA grants rare paediatric designation to Vanda’s CMT2S...

The FDA’s Office of Orphan Products Development and Office of Pediatric Therapeu...

Biocytogen and Whitehawk partner to develop ADCs

Under this collaboration, Biocytogen will offer access to up to five bispecific ...

India is one of Zoetis’ strongest markets in Asia for i...

The recent H5N1 avian influenza resurgence in poultry farms in certain district...

 Resilience by design: The packaging imperative

For a long time, pharma packaging was treated as a back-end function something ...

AI-driven QbD: Advancing predictive, data-driven pharma...

Introduction: Moving beyond conventional QbD Quality by Design (QbD) has become...

Vertex signs agreement to acquire Crinetics for $10bn

Approved unanimously by both companies’ boards, the acquisition will see Vertex ...

EC approves AbbVie’s Tepkinly combination for follicula...

The decision is based on data from the pivotal Phase III EPCORE FL-1 trial, whic...

Lessons from the Delhi–Agra–Puducherry counterfeit medi...

Introduction India is often described as the “pharmacy of the world.” Yet, the ...

University of Hawai’i Cancer Center Opens Hawaiʻi’s Fir...

The University of Hawaiʻi (UH) Cancer Center has opened the Hoʻōla Early Phase C...

Novartis to acquire Myricx Bio in up to $1.5bn deal

The deal includes an upfront payment of $1.1bn and up to $400m in potential mile...

Besins Healthcare boosts drug delivery portfolio with U...

UniD Manufacturing’s expertise includes advanced polymer systems used in complex...

Immuneel and Arogya Finance launch India’s first zero c...

Immuneel Therapeutics, India’s pioneering cell and gene therapy  company, annou...

FOPE seeks CDSCO clarification on pharmacovigilance obl...

The Federation of Pharma Entrepreneurs (FOPE) has sought clarifications from th...

The fine line between reform and risk 

A couple of recent notifications, one a notified amendment and the second one, ...